Sildenafil for pulmonary hypertension secondary to congenital heart diseases

Indian Heart Journal

Volumn 59, Issue 4, 2007, Pages 342-345

  Gupta, Anuja ^a,b   Kerkar, Prafulla ^a  

^a KEM HOSPITAL   (India)

^b NONE   (India)

Author keywords

Congenital heart diseases; Eisenmenger syndrome; Pulmonary hypertension

Indexed keywords

DIGOXIN; DIURETIC AGENT; SILDENAFIL;

ADOLESCENT; ADULT; ARTICLE; BLOOD OXYGENATION; BLOOD PRESSURE; BLOOD PRESSURE FLUCTUATION; BLOOD STORAGE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLOR VISION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; FLUSHING; FUNCTIONAL STATUS; HEADACHE; HUMAN; HYPERTRANSLUCENT LUNG; LUNG VASCULAR RESISTANCE; MALE; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT MONITORING; PHOTOSENSITIVITY; SCHOOL CHILD; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER; WEAKNESS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; EXERCISE TEST; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; SULFONES; TREATMENT OUTCOME;

EID: 37749017841     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958; (5099):755-62.
2. Rozenweig BE, Barst RJ. Pulmonary arterial hypertension: a comprehensive review of pharmacological treatment. Treat Respir Med 2006; 5(2):117-27
3. Rosenzweig BE, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999; 99(14):1858-65.
4. Malik AS, Warshafsky S, Lehrman S. Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension. Arch Intern Med 1997; 157(6):621-5.
5. Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S):56S-61S.
6. Kotlyar E, Sy R, Keogh AM, Kermeen F, Macdonald PS, Hayward CS, et al. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart disease. Cardiol Young 2006; 16(3):268-74.
7. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Eng j Med 2002; 346(12):896-903.
8. Reffelman T, Kloner R. Therapeutic potential of phosphodiesterase-5 inhibition for cardiovascular disease. Circulation 2003; 108(2):239-44.
9. Sastry BKS, Narasimhan C, Reddy K, Raju S. Clinical efficacy of sildenafil in primary pulmonary hypertension. J Am Coll Cardiol 2004; 43:1149-53.
10. Michelakis E, Tymchak W, Noga M, Webster L, Wu X, Lien D, Wang S, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003; 108(17):2066-69.
11. Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Eng J Med 1996; 343(18):1342-3.
12. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hubler M, et al. Intravenous Sildenafil is a potent pulmonary vasodilator in children with congenital heart diseases. Circulation 2003; 108(Suppl 1):167-73.
13. Atz AM, Lefler AK, Fairbrother DL, Uber WE, Bradley SM. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 2002; 124(3):628-9.
14. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 2003; 29(11):1996-2003.
15. Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 2006; 151:851.e1-5.
16. Padma-Nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F. A 4-year update on the safety of Sildenafil Citrate (Viagra). Urology 2002; 60(2 Suppl 2):67-90.